Incyte's Change in Accured Expenses fell 542.62% to $115.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.0 million, marking a year-over-year decrease of 15914.93%. This contributed to the annual value of $278.9 million for FY2024, which is 2095.49% up from last year.
Per Incyte's latest filing, its Change in Accured Expenses stood at $115.1 million for Q3 2025, which was down 542.62% from -$476.7 million recorded in Q2 2025.
Incyte's 5-year Change in Accured Expenses high stood at $129.8 million for Q4 2024, and its period low was -$476.7 million during Q2 2025.
Its 5-year average for Change in Accured Expenses is $30.2 million, with a median of $53.8 million in 2022.
Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 243045.93% in 2022, then crashed by 51089.61% in 2025.
Over the past 5 years, Incyte's Change in Accured Expenses (Quarter) stood at $46.4 million in 2021, then grew by 3.04% to $47.8 million in 2022, then skyrocketed by 143.08% to $116.2 million in 2023, then rose by 11.66% to $129.8 million in 2024, then fell by 11.28% to $115.1 million in 2025.
Its last three reported values are $115.1 million in Q3 2025, -$476.7 million for Q2 2025, and $74.8 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value